Article
Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.
Brain : a journal of neurology - 1 Apr 2013
DeLuca Gabriele C, Alterman Rose, Martin Jenny L, Mittal Arunesh, Blundell Samkeliso, Bird Shannon, Beale Harry, Hong Lai San, Esiri Margaret M
Abstract excerpt
Clinical heterogeneity in multiple sclerosis is the rule. Evidence suggests that HLA-DRB1*15 may play a role in clinical outcome. Spinal cord pathology is common and contributes significantly to disability in the disease. The influence of HLA-DRB1*15 on multiple sclerosis spinal cord pathology is unknown. A post-mortem cohort of pathologically confirmed cases with multiple sclerosis (n = 108, 34 males) with fresh...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
